Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol Spiromax in EIB
NCT01791972Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Mar 2013
- Primary completion
- May 2013
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of albuterol spiromax in Exercise-induced bronchoconstriction (EIB), sponsored by Teva Pharmaceutical Industries Ltd.. Started Mar 2013; status: completed.
02
Drugs
albuterol spiromax
03
Conditions
Exercise-induced bronchoconstriction (EIB)
Beyond the preview
Go deeper on NCT01791972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01791972.